Lung Cancer Diagnostic Tests Market Report

Europe Lung Cancer Diagnostic Tests Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 26, 2020
  • PAGES：180
  • REPORT CODE：GMM587606
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring demand for screening tools and techniques across the world. Rising awareness and supportive government initiatives are some additional factors anticipated to boost market growth during the forecast period.

    The Lung Cancer Diagnostic Tests market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Lung Cancer Diagnostic Tests Market Segmentations:

    By Player:

    • Advpharma Inc

    • Emory Healthcare Austrian Institute of Technology GmbH

    • AIT

    • HalioDx LLC

    • Emory University

    • GlycoZym

    • Mayo Clinic

    • Courtagen Life Sciences Inc SAS

    • BioMarker Strategies US

    By Type:

    • Immunoassays

    • Flow Cytometry

    • Rapid Tests

    • Molecular Assays

    • Tissue Arrays

    • Circulating Tumor Cells

    • Pharmacodiagnostics

    • Biomarkers

    • Other Diagnostics Methods

    By End-User:

    • Precision Medicine

    • Personalized Medicine

    • Cancer Monitoring

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Lung Cancer Diagnostic Tests Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays from 2014 to 2026

    • 1.3.2 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry from 2014 to 2026

    • 1.3.3 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests from 2014 to 2026

    • 1.3.4 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays from 2014 to 2026

    • 1.3.5 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays from 2014 to 2026

    • 1.3.6 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells from 2014 to 2026

    • 1.3.7 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics from 2014 to 2026

    • 1.3.8 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers from 2014 to 2026

    • 1.3.9 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2014 to 2026

    • 1.4.2 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • 1.4.3 Europe Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Lung Cancer Diagnostic Tests Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Lung Cancer Diagnostic Tests by Major Types

      • 3.4.1 Market Size and Growth Rate of Immunoassays

      • 3.4.2 Market Size and Growth Rate of Flow Cytometry

      • 3.4.3 Market Size and Growth Rate of Rapid Tests

      • 3.4.4 Market Size and Growth Rate of Molecular Assays

      • 3.4.5 Market Size and Growth Rate of Tissue Arrays

      • 3.4.6 Market Size and Growth Rate of Circulating Tumor Cells

      • 3.4.7 Market Size and Growth Rate of Pharmacodiagnostics

      • 3.4.8 Market Size and Growth Rate of Biomarkers

      • 3.4.9 Market Size and Growth Rate of Other Diagnostics Methods

    4 Segmentation of Lung Cancer Diagnostic Tests Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Lung Cancer Diagnostic Tests by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Precision Medicine for Construction

      • 4.4.2 Market Size and Growth Rate of Personalized Medicine for Construction

      • 4.4.3 Market Size and Growth Rate of Cancer Monitoring for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Lung Cancer Diagnostic Tests Production Analysis by Top Regions

    • 5.2 Europe Lung Cancer Diagnostic Tests Consumption Analysis by Top Regions

    • 5.3 Europe Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.3 France Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    6 Product Circulation of Lung Cancer Diagnostic Tests Market among Top Countries

    • 6.1 Top 5 Export Countries in Lung Cancer Diagnostic Tests Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Lung Cancer Diagnostic Tests Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Lung Cancer Diagnostic Tests Landscape Analysis

    • 7.1 Germany Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 7.2 Germany Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    8. UK Lung Cancer Diagnostic Tests Landscape Analysis

    • 8.1 UK Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 8.2 UK Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    9. France Lung Cancer Diagnostic Tests Landscape Analysis

    • 9.1 France Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 9.2 France Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    10. Italy Lung Cancer Diagnostic Tests Landscape Analysis

    • 10.1 Italy Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 10.2 Italy Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    11. Spain Lung Cancer Diagnostic Tests Landscape Analysis

    • 11.1 Spain Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 11.2 Spain Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    12. Poland Lung Cancer Diagnostic Tests Landscape Analysis

    • 12.1 Poland Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 12.2 Poland Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    13. Russia Lung Cancer Diagnostic Tests Landscape Analysis

    • 13.1 Russia Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 13.2 Russia Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    14. Switzerland Lung Cancer Diagnostic Tests Landscape Analysis

    • 14.1 Switzerland Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 14.2 Switzerland Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    15. Turkey Lung Cancer Diagnostic Tests Landscape Analysis

    • 15.1 Turkey Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 15.2 Turkey Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Landscape Analysis by Top Countries

      • 16.3.1 Denmark Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 16.3.2 Finland Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 16.3.3 Norway Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 16.3.4 Sweden Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 16.3.6 Iceland Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Landscape Analysis by Top Countries

      • 17.3.1 Belgium Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 17.3.2 Netherlands Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 17.3.3 Luxembourg Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Landscape Analysis by Top Countries

      • 18.3.1 Estonia Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 18.3.2 Latvia Lung Cancer Diagnostic Tests Market Volume and Growth Rate

      • 18.3.3 Lithuania Lung Cancer Diagnostic Tests Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Advpharma Inc

      • 19.1.1 Advpharma Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Emory Healthcare Austrian Institute of Technology GmbH

      • 19.2.1 Emory Healthcare Austrian Institute of Technology GmbH Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 AIT

      • 19.3.1 AIT Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 HalioDx LLC

      • 19.4.1 HalioDx LLC Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Emory University

      • 19.5.1 Emory University Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlycoZym

      • 19.6.1 GlycoZym Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Mayo Clinic

      • 19.7.1 Mayo Clinic Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Courtagen Life Sciences Inc SAS

      • 19.8.1 Courtagen Life Sciences Inc SAS Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 BioMarker Strategies US

      • 19.9.1 BioMarker Strategies US Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    The List of Tables and Figures (Totals 95 Figures and 164 Tables)

    • Figure Product Picture

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2014 to 2026

    • Figure Germany Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure UK Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure France Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Lung Cancer Diagnostic Tests Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Lung Cancer Diagnostic Tests Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Lung Cancer Diagnostic Tests

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different Types from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Immunoassays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Flow Cytometry Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Rapid Tests Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Molecular Assays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Tissue Arrays Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Circulating Tumor Cells Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Pharmacodiagnostics Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Biomarkers Market, 2015 - 2026 (USD Million)

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Other Diagnostics Methods Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Table Consumption Share of Lung Cancer Diagnostic Tests by Different End-Users from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Precision Medicine from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Personalized Medicine from 2014 to 2026

    • Figure Lung Cancer Diagnostic Tests Market Size and Growth Rate of Cancer Monitoring from 2014 to 2026

    • Table Europe Lung Cancer Diagnostic Tests Production by Major Regions

    • Table Europe Lung Cancer Diagnostic Tests Production Share by Major Regions

    • Figure Europe Lung Cancer Diagnostic Tests Production Share by Major Countries and Regions in 2014

    • Table Europe Lung Cancer Diagnostic Tests Consumption by Major Regions

    • Table Europe Lung Cancer Diagnostic Tests Consumption Share by Major Regions

    • Table Germany Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table UK Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table France Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Italy Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Spain Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Poland Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Russia Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Switzerland Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Turkey Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Lung Cancer Diagnostic Tests Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Germany Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Germany Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Germany Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table UK Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table UK Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table UK Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table UK Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table France Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table France Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table France Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table France Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Italy Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Italy Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Italy Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Italy Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Spain Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Spain Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Spain Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Spain Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Poland Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Poland Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Poland Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Poland Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Russia Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Russia Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Russia Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Russia Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Switzerland Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Switzerland Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Switzerland Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Turkey Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Turkey Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Turkey Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Lung Cancer Diagnostic Tests Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Lung Cancer Diagnostic Tests Market Volume and Growth Rate from 2014 to 2026

    • Table Advpharma Inc Profiles

    • Table Advpharma Inc Production, Value, Price, Gross Margin 2014-2019

    • Table Advpharma Inc Product benchmarking

    • Table Advpharma Inc Strategic initiatives

    • Table Advpharma Inc SWOT analysis

    • Table Emory Healthcare Austrian Institute of Technology GmbH Profiles

    • Table Emory Healthcare Austrian Institute of Technology GmbH Production, Value, Price, Gross Margin 2014-2019

    • Table Emory Healthcare Austrian Institute of Technology GmbH Product benchmarking

    • Table Emory Healthcare Austrian Institute of Technology GmbH Strategic initiatives

    • Table Emory Healthcare Austrian Institute of Technology GmbH SWOT analysis

    • Table AIT Profiles

    • Table AIT Production, Value, Price, Gross Margin 2014-2019

    • Table AIT Product benchmarking

    • Table AIT Strategic initiatives

    • Table AIT SWOT analysis

    • Table HalioDx LLC Profiles

    • Table HalioDx LLC Production, Value, Price, Gross Margin 2014-2019

    • Table HalioDx LLC Product benchmarking

    • Table HalioDx LLC Strategic initiatives

    • Table HalioDx LLC SWOT analysis

    • Table Emory University Profiles

    • Table Emory University Production, Value, Price, Gross Margin 2014-2019

    • Table Emory University Product benchmarking

    • Table Emory University Strategic initiatives

    • Table Emory University SWOT analysis

    • Table GlycoZym Profiles

    • Table GlycoZym Production, Value, Price, Gross Margin 2014-2019

    • Table GlycoZym Product benchmarking

    • Table GlycoZym Strategic initiatives

    • Table GlycoZym SWOT analysis

    • Table Mayo Clinic Profiles

    • Table Mayo Clinic Production, Value, Price, Gross Margin 2014-2019

    • Table Mayo Clinic Product benchmarking

    • Table Mayo Clinic Strategic initiatives

    • Table Mayo Clinic SWOT analysis

    • Table Courtagen Life Sciences Inc SAS Profiles

    • Table Courtagen Life Sciences Inc SAS Production, Value, Price, Gross Margin 2014-2019

    • Table Courtagen Life Sciences Inc SAS Product benchmarking

    • Table Courtagen Life Sciences Inc SAS Strategic initiatives

    • Table Courtagen Life Sciences Inc SAS SWOT analysis

    • Table BioMarker Strategies US Profiles

    • Table BioMarker Strategies US Production, Value, Price, Gross Margin 2014-2019

    • Table BioMarker Strategies US Product benchmarking

    • Table BioMarker Strategies US Strategic initiatives

    • Table BioMarker Strategies US SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US